Japan and Germany have made particularly important contributions to understanding corticobasal degeneration (CBD) through detailed neuropathological case series. These research traditions, with their emphasis on detailed neuroanatomical mapping and clinicopathological correlation, have provided critical insights into the heterogeneity of CBD.
Japanese neuropathologists have been instrumental in characterizing CBD since the disorder was first described. Key contributions include:
Wada et al. (2009) - This landmark study examined the neuropathological features of CBD in 22 Japanese patients, establishing the baseline characteristics of 4-repeat tau pathology in this population@japanese2009. The study detailed the distribution of tau-positive neurons and glia, the characteristic astrocytic plaques, and the pattern of gray matter involvement.
Japanese researchers have made particularly important observations about 4-repeat tau:
Togo & Sahara (2011) - Detailed analysis of 4-repeat tau pathology in Japanese CBD cases established the preferential accumulation of 4R tau isoforms in astrocytic plaques and coiled bodies@tau2011. This work helped explain the biochemical basis of CBD and distinguished it from other tauopathies.
Japanese neuropathologists have provided the most detailed characterization of astrocytic plaques:
Kanamori et al. (2012) - Comprehensive analysis of astrocytic plaques in Japanese CBD cases@astrocyte2012. This study demonstrated that astrocytic plaques are a hallmark feature of CBD, distinguishing it from PSP where "tufted astrocytes" are the characteristic finding. The study also correlated astrocytic plaque density with clinical phenotype.
Japanese multicenter studies have clarified the frequency of alpha-synuclein pathology:
Saito et al. (2020) - Large Japanese series examining alpha-synuclein co-pathology in CBD@alpha2020. This study found that approximately 20-25% of clinically diagnosed CBD cases show Lewy body pathology at autopsy, often with clinical features suggestive of underlying synucleinopathy (such as REM sleep behavior disorder).
Higashi et al. (2018) - Detailed biochemical analysis of phosphorylated tau species in Japanese CBD cases@p-tau2018. This work characterized the specific tau phosphorylation sites and their relationship to clinical phenotype, showing distinct patterns from PSP.
Kurosaki et al. (2019) - Analysis of genetic features in Japanese CBD patients@genetic2019. This study examined MAPT haplotypes, GRN mutations, and other genetic factors in a Japanese cohort, demonstrating both similarities and differences from Caucasian populations.
German neuropathologists have contributed large, well-characterized autopsy series:
Boehme et al. (2010) - Neuropathological analysis of German CBD patients providing detailed characterization of cortical and subcortical involvement@german2010. This study emphasized the asymmetric nature of pathology and the variable involvement of different brain regions.
Mohl et al. (2014) - Important comparative study of PSP and CBD from German brain banks@PSP-CBD2014. This work provided detailed side-by-side pathological comparison, identifying key distinguishing features and overlapping characteristics.
German researchers have emphasized neuroinflammatory aspects:
von Economo neurons - German studies have specifically examined the vulnerability of von Economo neurons in the anterior cingulate and frontoinsular cortex in CBD, showing selective loss that correlates with behavioral variant FTD features.
Spiegel et al. (2017) - Analysis of neuroinflammatory changes in German CBD cases@neuroinflammation2017. This study demonstrated prominent microglial activation and its correlation with tau pathology burden.
Neumann et al. (2015) - German series examining TDP-43 pathology in CBD@oliver2015. This work showed that TDP-43 pathology is present in approximately 40-50% of CBD cases, often in the form of neurites and cytoplasmic inclusions, though less commonly than in FTLD-TDP.
Both Japanese and German series have emphasized that CBD is pathologically heterogeneous:
| Pathological Subtype | Typical Clinical Phenotype | Key Pathological Features |
|---|---|---|
| Classic CBD | CBS with cortical signs | Astrocytic plaques, asymmetric cortical atrophy |
| CBD-FTD | Behavioral variant FTD | Orbitofrontal/temporal involvement, TDP-43 |
| CBD-PSP | Richardson syndrome | PSP-like tau distribution, tufted astrocytes |
| AD-CBS | CBS with memory impairment | Amyloid plaques, NFT, limbic tau |
Both traditions have documented consistent patterns:
Japanese and German studies typically employ:
Both research traditions emphasize:
These case series have directly influenced:
Despite extensive Japanese and German contributions, key questions remain: